Trevena, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2014

6. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

	December 31,
	2014		2013
Compensation and benefits	$	1,628,102	$	859,444
Clinical trial fees		846,199		762,687
Other research and development expenses		96,088		507,845
Professional services		—		24,005
Other accrued expenses and other current liabilities		7,880		4,811

Total accrued expenses and other current liabilities	$	2,578,269	$	2,158,792